Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 2015
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer, Jüri Reimand, Xiaoyang Lan, et al.
NPJ Breast Cancer
|
June 27, 2017
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
Jane Bayani, Cindy Q Yao, Mary Anne Quintayo, et al.
NPJ Breast Cancer
|
July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study
John M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Breast Cancer Research and Treatment
|
February 5, 2026
Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy
Andréanne Leblanc, Ana-Alicia Beltran-Bless, Gregory R Pond, et al.
Breast (Edinburgh, Scotland)
|
July 9, 2025
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?
Ana-Alicia Beltran-Bless, Gregory R Pond, Jane Bayani, et al.
Cancer Research Communications
|
October 22, 2025
Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer
Anil Abraham Joy, Nicholas Cheng, Karen A Gelmon, et al.
Journal of the National Cancer Institute
|
June 20, 2018
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial
Antonia K Roseweir, Lindsay Bennett, Ashley Dickson, et al.
Journal of the National Cancer Institute
|
May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
John M S Bartlett, Jane Bayani, Andrea Marshall, et al.
Journal of Medical Internet Research
|
April 14, 2026
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study
Lisa Pilgram, Kai Yang, Ana-Alicia Beltran-Bless, et al.
Breast Cancer Research and Treatment
|
June 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 2015
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer, Jüri Reimand, Xiaoyang Lan, et al.
NPJ Breast Cancer
|
June 27, 2017
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
Jane Bayani, Cindy Q Yao, Mary Anne Quintayo, et al.
NPJ Breast Cancer
|
July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study
John M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Breast Cancer Research and Treatment
|
February 5, 2026
Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy
Andréanne Leblanc, Ana-Alicia Beltran-Bless, Gregory R Pond, et al.
Breast (Edinburgh, Scotland)
|
July 9, 2025
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?
Ana-Alicia Beltran-Bless, Gregory R Pond, Jane Bayani, et al.
Cancer Research Communications
|
October 22, 2025
Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer
Anil Abraham Joy, Nicholas Cheng, Karen A Gelmon, et al.
Journal of the National Cancer Institute
|
June 20, 2018
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial
Antonia K Roseweir, Lindsay Bennett, Ashley Dickson, et al.
Journal of the National Cancer Institute
|
May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
John M S Bartlett, Jane Bayani, Andrea Marshall, et al.
Journal of Medical Internet Research
|
April 14, 2026
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study
Lisa Pilgram, Kai Yang, Ana-Alicia Beltran-Bless, et al.
Breast Cancer Research and Treatment
|
June 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, et al.
Page
of 9